{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T20:40:23Z","timestamp":1792269623857,"version":"4.4.0"},"reference-count":19,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T00:00:00Z","timestamp":1788825600000},"content-version":"vor","delay-in-days":250,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Case Reports in Endocrinology"],"published-print":{"date-parts":[[2026,1]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Hypertriglyceridaemia (HTG) is a common condition resulting from genetic and environmental factors. Second\u2010generation antipsychotic (SGA) medications are classically associated with the development of metabolic syndrome, of which HTG is a hallmark feature. Severe HTG is the third most common cause of acute pancreatitis, which has significant associated morbidity and mortality risk. It is therefore vital to rapidly and sustainably reduce triglyceride levels in patients presenting with severe HTG.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Clinical Case<\/jats:title>\n                    <jats:p>A 35\u2010year\u2010old gentleman with a history of psychiatric illness taking SGA medications (quetiapine and risperidone) presented to our hospital with apparent hyponatraemia. With associated hyperosmolality (302\u2009mOsm\/kg), a diagnosis of pseudohyponatraemia was made. Upon further investigation, pseudohyponatraemia was identified to be due to severe HTG (72.8\u2009mmol\/L) and hyperglycaemia (26.0\u2009mmol\/L). There were no clinical or biochemical features of pancreatitis. A variable\u2010rate infusion of intravenous insulin was commenced. Over the 10\u2010day admission a fall in triglycerides to 10.5\u2009mmol\/L was observed without any adverse events. Acute pancreatitis did not develop during the inpatient admission or during outpatient follow\u2010up, and triglyceride levels have fallen substantially (3.2\u2009mmol\/L at 5 months) having been switched from quetiapine and risperidone to aripiprazole, an SGA associated with less metabolic disturbance.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This case demonstrates the safe and effective management of SGA\u2010associated severe HTG with intravenous insulin infusion to prevent acute pancreatitis. It also highlights the utility of pseudohyponatraemia as a useful way of detecting severe HTG and the impact of SGA medications in the aetiology of severe HTG.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1155\/crie\/2376136","type":"journal-article","created":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T05:48:04Z","timestamp":1788932884000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Diagnosis of Antipsychotic Medication\u2010Induced Severe Hypertriglyceridaemia by the Phenomenon of Pseudohyponatraemia and Successful Management With Variable\u2010Rate Intravenous Insulin Infusion: A Case Report"],"prefix":"10.1155","volume":"2026","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-4857-2031","authenticated-orcid":false,"given":"Adam","family":"Coleman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0572-0165","authenticated-orcid":false,"given":"Grace","family":"Kettyle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8611-8648","authenticated-orcid":false,"given":"Monica","family":"Monaghan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-0114-6554","authenticated-orcid":false,"given":"Edward","family":"McKeever","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2026,9,8]]},"reference":[{"key":"e_1_2_13_1_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.arteri.2020.04.001"},{"key":"e_1_2_13_2_2","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.27.2.596"},{"key":"e_1_2_13_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2015.07.022"},{"key":"e_1_2_13_4_2","doi-asserted-by":"publisher","DOI":"10.1017\/S0033291721002853"},{"key":"e_1_2_13_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)31310-6"},{"key":"e_1_2_13_6_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.mcg.0000436438.60145.5a"},{"key":"e_1_2_13_7_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197310182891607"},{"key":"e_1_2_13_8_2","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-19-0101"},{"key":"e_1_2_13_9_2","doi-asserted-by":"publisher","DOI":"10.1177\/10600280211070102"},{"key":"e_1_2_13_10_2","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.870067"},{"key":"e_1_2_13_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejim.2014.08.008"},{"key":"e_1_2_13_12_2","doi-asserted-by":"publisher","DOI":"10.1159\/000095425"},{"key":"e_1_2_13_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/S2215-0366(19)30416-X"},{"key":"e_1_2_13_14_2","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12124076"},{"key":"e_1_2_13_15_2","doi-asserted-by":"publisher","DOI":"10.1373\/clinchem.2005.054981"},{"key":"e_1_2_13_16_2","doi-asserted-by":"publisher","DOI":"10.1093\/ijnp\/pyaa026"},{"key":"e_1_2_13_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2024.117545"},{"key":"e_1_2_13_18_2","doi-asserted-by":"publisher","DOI":"10.1186\/s13063-019-3498-x"},{"key":"e_1_2_13_19_2","doi-asserted-by":"publisher","DOI":"10.31486\/toj.17.0059"}],"container-title":["Case Reports in Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1155\/crie\/2376136","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1155\/crie\/2376136","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1155\/crie\/2376136","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T05:48:05Z","timestamp":1788932885000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1155\/crie\/2376136"}},"subtitle":[],"editor":[{"given":"Kalyani","family":"Sen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":19,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["10.1155\/crie\/2376136"],"URL":"https:\/\/doi.org\/10.1155\/crie\/2376136","archive":["Portico"],"relation":{},"ISSN":["2090-6501","2090-651X"],"issn-type":[{"value":"2090-6501","type":"print"},{"value":"2090-651X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"2025-08-20","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-08-25","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-09-08","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"2376136"}}